Left: Paul Wagner, chairman and CEO of Forte Biosciences; Right: Christopher Roenfeldt, COO at Forte Biosciences [Photos: Forte/LinkedIn]
Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion....